![Kate Redwood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kate Redwood
Directeur/Membre du Conseil chez Melbourne Health
Profil
Kate Redwood is currently a Director at Melbourne Health.
Previously, she worked as the Chief Executive Officer at the Australian Physiotherapy Association and as a Director at The Walter & Eliza Hall Institute of Medical Research.
She obtained an undergraduate degree from Monash University.
Postes actifs de Kate Redwood
Sociétés | Poste | Début |
---|---|---|
Melbourne Health | Directeur/Membre du Conseil | 08/08/2011 |
Anciens postes connus de Kate Redwood
Sociétés | Poste | Fin |
---|---|---|
Australian Physiotherapy Association | President | - |
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | - |
Formation de Kate Redwood
Monash University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
Australian Physiotherapy Association | |
Melbourne Health |